Literature DB >> 8570531

New evaluation method for in vitro/in vivo correlation of enteric-coated multiple unit dosage forms.

T Hayashi1, T Ogura, Y Takagishi.   

Abstract

PURPOSE: To establish the evaluating method for drug dissolution profiles in the gastrointestinal (GI) tract based on in vitro data for the enteric-coated multiple unit.
METHODS: Dissolution profile in the GI tract was calculated by the convolution procedure using an in vitro dissolution profile as a weighting function, and the gastric-emptying (GE) process as an input function (GE-convolution method). A computer program, GECONV, was developed for numerical execution of the convolution integral.
RESULTS: The in vivo dissolution profile of enteric-coated aspirin granules estimated by GE-convolution was in good agreement with the in vivo cumulative absorption profile calculated by the Wagner-Nelson method using the plasma concentration data after oral administration to healthy subjects. The in vitro/in vivo correlation improved markedly by taking the GE process into consideration.
CONCLUSIONS: These findings indicated that this convolution method is useful for estimating the in vivo dissolution profile of drugs, when they are administered in an enteric-coated multiple unit type dosage form, because the gastric emptying process is a determinant process for the in vivo drug dissolution.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570531     DOI: 10.1023/a:1016277724645

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  FACTORS INFLUENCING THE PLASMA SALICYLATE CONCENTRATION AND URINARY SALICYLATE EXCRETION AFTER ORAL DOSAGE WITH ASPIRIN.

Authors:  A J CUMMINGS; B K MARTIN
Journal:  Biochem Pharmacol       Date:  1964-05       Impact factor: 5.858

2.  EFFECT OF CERTAIN TABLET FORMULATION FACTORS ON DISSOLUTION RATE OF THE ACTIVE INGREDIENT. I. IMPORTANCE OF USING APPROPRIATE AGITATION INTENSITIES FOR IN VITRO DISSOLUTION RATE MEASUREMENTS TO REFLECT IN VIVO CONDITIONS.

Authors:  G LEVY
Journal:  J Pharm Sci       Date:  1963-11       Impact factor: 3.534

3.  ASPIRIN FORMULATION AND ABSORPTION RATE. I. CRITERIA FOR SERUM MEASUREMENTS WITH HUMAN PANELS.

Authors:  S V LIEBERMAN; S R KRAUS; J MURRAY; J H WOOD
Journal:  J Pharm Sci       Date:  1964-12       Impact factor: 3.534

4.  KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1964-11       Impact factor: 3.534

5.  New results on an in vitro model for the study of the influence of fatty meals on the bioavailability of theophylline controlled-release formulations.

Authors:  J M Aiache; N Pierre; E Beyssac; V K Prasad; J P Skelly
Journal:  J Pharm Sci       Date:  1989-03       Impact factor: 3.534

6.  Bioavailability of sugar-coated tablets of thiamine disulfide in humans. I. Effect of gastric acidity and in vivo-in vitro correlation.

Authors:  N Aoyagi; H Ogata; N Kaniwa; M Koibuchi; T Shibazaki; A Ejima; M Mizobe; K Kohno; M Samejima
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-01       Impact factor: 1.645

7.  A method for continuous pH regulation of dissolution medium in stirred vessels.

Authors:  P J Waaler
Journal:  J Pharm Sci       Date:  1993-07       Impact factor: 3.534

8.  Mathematical basis of point-area deconvolution method for determining in vivo input functions.

Authors:  D P Vaughan; M Dennis
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

9.  In vitro and in vivo correlation for controlled-release formulation of d-chlorpheniramine maleate.

Authors:  N Katori; K Okudaira; N Aoyagi; Y Takeda; M Uchiyama
Journal:  J Pharmacobiodyn       Date:  1991-10
  9 in total
  4 in total

1.  Bias in the Wagner-Nelson estimate of the fraction of drug absorbed.

Authors:  Yibin Wang; Jerry Nedelman
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  Modeling in frequency domain used for assessment of in vivo dissolution profile.

Authors:  M Durisová; L Dedík
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

3.  Assessment of the gastric emptying velocity by the 13C-octanoate breath test: deconvolution versus a Wagner-Nelson analysis.

Authors:  Masaki Sanaka; Takatsugu Yamamoto; Yukako Osaki; Yasushi Kuyama
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

4.  A system-approach method for the adjustment of time-varying continuous drug infusion in individual patients: a simulation study.

Authors:  Mária Durisová; Ladislav Dedík
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-12       Impact factor: 2.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.